Convergent transcriptomic and genomic evidence supporting a dysregulation of CXCL16 and CCL5 in Alzheimer’s disease

BACKGROUND: Neuroinflammatory factors, especially chemokines, have been widely reported to be involved in the pathogenesis of Alzheimer’s disease (AD). It is unclear how chemokines are altered in AD, and whether dysregulation of chemokines is the cause, or the consequence, of the disease. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao, Zhang, Deng-Feng, Bi, Rui, Tan, Li-Wen, Chen, Xiaogang, Xu, Min, Yao, Yong-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863145/
https://www.ncbi.nlm.nih.gov/pubmed/36670424
http://dx.doi.org/10.1186/s13195-022-01159-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863145/
https://www.ncbi.nlm.nih.gov/pubmed/36670424
http://dx.doi.org/10.1186/s13195-022-01159-5

Ejemplares similares